160 related articles for article (PubMed ID: 17375673)
1. [Carbohydrate-binding proteins of marine invertebrates].
Luk'ianov PA; Chernikov OV; Kobelev SS; Chikalovets IV; Molchanova VI; Li W
Bioorg Khim; 2007; 33(1):172-81. PubMed ID: 17375673
[TBL] [Abstract][Full Text] [Related]
2. A beta-galactose-specific lectin isolated from the marine worm Chaetopterus variopedatus possesses anti-HIV-1 activity.
Wang JH; Kong J; Li W; Molchanova V; Chikalovets I; Belogortseva N; Luk'yanov P; Zheng YT
Comp Biochem Physiol C Toxicol Pharmacol; 2006; 142(1-2):111-7. PubMed ID: 16316787
[TBL] [Abstract][Full Text] [Related]
3. A new lectin from the sea worm Serpula vermicularis: isolation, characterization and anti-HIV activity.
Molchanova V; Chikalovets I; Chernikov O; Belogortseva N; Li W; Wang JH; Yang DY; Zheng YT; Lukyanov P
Comp Biochem Physiol C Toxicol Pharmacol; 2007 Mar; 145(2):184-93. PubMed ID: 17258940
[TBL] [Abstract][Full Text] [Related]
4. Anti-HIV activity of extracts and compounds from marine algae.
Kim SK; Karadeniz F
Adv Food Nutr Res; 2011; 64():255-65. PubMed ID: 22054953
[TBL] [Abstract][Full Text] [Related]
5. Antiviral lectins as potential HIV microbicides.
Koharudin LM; Gronenborn AM
Curr Opin Virol; 2014 Aug; 7():95-100. PubMed ID: 25010042
[TBL] [Abstract][Full Text] [Related]
6. Structural studies of algal lectins with anti-HIV activity.
Ziółkowska NE; Wlodawer A
Acta Biochim Pol; 2006; 53(4):617-26. PubMed ID: 17128290
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
[TBL] [Abstract][Full Text] [Related]
8. Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention.
Auwerx J; François KO; Covens K; Van Laethem K; Balzarini J
Virology; 2008 Dec; 382(1):10-9. PubMed ID: 18930512
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
[TBL] [Abstract][Full Text] [Related]
10. Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions.
Bertaux C; Daelemans D; Meertens L; Cormier EG; Reinus JF; Peumans WJ; Van Damme EJ; Igarashi Y; Oki T; Schols D; Dragic T; Balzarini J
Virology; 2007 Sep; 366(1):40-50. PubMed ID: 17498767
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-HIV-1 activity of new MKC-442 analogues with an alkynyl-substituted 6-benzyl group.
Aly YL; Pedersen EB; La Colla P; Loddo R
Arch Pharm (Weinheim); 2007 May; 340(5):225-35. PubMed ID: 17464964
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a highly efficient anti-HIV pol hammerhead ribozyme.
Müller-Kuller T; Capalbo G; Klebba C; Engels JW; Klein SA
Oligonucleotides; 2009 Sep; 19(3):265-72. PubMed ID: 19732019
[TBL] [Abstract][Full Text] [Related]
13. Anti-AIDS agents 66: syntheses and anti-HIV activity of phenolic and aza 3',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone (DCK) derivatives.
Suzuki M; Yu D; Morris-Natschke SL; Smith PC; Lee KH
Bioorg Med Chem; 2007 Nov; 15(21):6852-8. PubMed ID: 17719228
[TBL] [Abstract][Full Text] [Related]
14. Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models.
Buffa V; Stieh D; Mamhood N; Hu Q; Fletcher P; Shattock RJ
J Gen Virol; 2009 Jan; 90(Pt 1):234-43. PubMed ID: 19088294
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of human immunodeficiency virus entry inhibitors: sulfonamide as an isostere for the alpha-ketoamide group.
Lu RJ; Tucker JA; Zinevitch T; Kirichenko O; Konoplev V; Kuznetsova S; Sviridov S; Pickens J; Tandel S; Brahmachary E; Yang Y; Wang J; Freel S; Fisher S; Sullivan A; Zhou J; Stanfield-Oakley S; Greenberg M; Bolognesi D; Bray B; Koszalka B; Jeffs P; Khasanov A; Ma YA; Jeffries C; Liu C; Proskurina T; Zhu T; Chucholowski A; Li R; Sexton C
J Med Chem; 2007 Dec; 50(26):6535-44. PubMed ID: 18052117
[TBL] [Abstract][Full Text] [Related]
16. Primary structure and carbohydrate binding specificity of a potent anti-HIV lectin isolated from the filamentous cyanobacterium Oscillatoria agardhii.
Sato Y; Okuyama S; Hori K
J Biol Chem; 2007 Apr; 282(15):11021-9. PubMed ID: 17314091
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB kinase with noraristeromycin.
Asamitsu K; Yamaguchi T; Nakata K; Hibi Y; Victoriano AF; Imai K; Onozaki K; Kitade Y; Okamoto T
J Biochem; 2008 Nov; 144(5):581-9. PubMed ID: 18713798
[TBL] [Abstract][Full Text] [Related]
18. trans-Platinum reporting for duty.
Burdette S
Chem Biol; 2006 May; 13(5):465-7. PubMed ID: 16720266
[TBL] [Abstract][Full Text] [Related]
19. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
[TBL] [Abstract][Full Text] [Related]
20. Current trends of lectins from microfungi.
Singh RS; Bhari R; Kaur HP
Crit Rev Biotechnol; 2011 Sep; 31(3):193-210. PubMed ID: 20919955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
